Large cell neuroendocrine carcinoma of the lung: chemotherapy regimen depends on how “large” your diagnostic criteria are

Giulio Rossi, Lucia Longo, Fausto Barbieri, Federica Bertolini, Paolo Spagnolo

Source: Eur Respir J, 50 (4) 1701292; 10.1183/13993003.01292-2017

Journal Issue: October

Disease area: Thoracic oncology

Rating:

You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Giulio Rossi, Lucia Longo, Fausto Barbieri, Federica Bertolini, Paolo Spagnolo. Large cell neuroendocrine carcinoma of the lung: chemotherapy regimen depends on how “large” your diagnostic criteria are. Eur Respir J, 50 (4) 1701292; 10.1183/13993003.01292-2017

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.

You must Login to comment this presentation.

Related content which might interest you:

Chemotherapy for pulmonary large cell neuroendocrine carcinomas: does the regimen matter? Source: Eur Respir J, 49 (6) 1601838; 10.1183/13993003.01838-2016 Year: 2017
Treatment of extensive-stage small cell lung carcinoma: current status and future prospects Source: Eur Respir J 2010; 35: 202-215 Year: 2010
Clinical characteristics of large cell neuroendocrine carcinoma of the lung Source: Eur Respir J 2004; 24: Suppl. 48, 531s Year: 2004
Small cell lung cancer: local control with an alternate chemoradiation schedule Source: Eur Respir J 2001; 18: Suppl. 33, 395s Year: 2001
Can IASLC/ATS/ERS subtype help predict response to chemotherapy in small biopsies of advanced lung adenocarcinoma? Source: Eur Respir J 2014; 43: 1240-1242 Year: 2014
Long-term survival of the patients with advanced non small cell lung carcinomas after induction chemotherapy Source: Eur Respir J 2005; 26: Suppl. 49, 78s Year: 2005
Treatment of limited disease-small cell lung cancer Source: Eur Respir Mon; 2009: 44: 299–309 Year: 2009
Radiotherapy in small cell lung cancer: patient options Source: Virtual Congress 2020 – Thoracic oncology Year: 2020
Respective indications of chemotherapy, radiotherapy and surgery in limited disease stage small cell lung carcinoma Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005
TTF-1 for prediction of response to chemotherapy in patients with locally advanced or metastatic small cell lung cancer (SCLC) Source: Annual Congress 2012 - Treatment of lung cancer Year: 2012
Should there be a specific management for large cell neuroendocrine carcinoma? Source: Annual Congress 2005 - Neuroendocrine tumours of the lung Year: 2005
Impact of radiotherapy on outcomes of nivolumab in advanced non-small cell lung cancer: a case controlled study Source: International Congress 2018 – Lung cancer: personalised medicine Year: 2018
Management of extensive disease-small cell lung cancer Source: Eur Respir Mon; 2009: 44: 310–317 Year: 2009
Clinicopathological prognostic factors in operated for small cell lung carcinoma or large cell neuroendocrine carcinoma patients Source: Annual Congress 2013 –Lung cancer resection and radiotherapy and thoracic oncology late breaking abstracts Year: 2013
Radiotherapy vs. radio-chemotherapy of the inoperable non small cell lung cancer - a phase-III-study Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001
Stage I-IIIa small cell lung cancer (SCLC): multimodal therapy including surgery Source: Eur Respir J 2001; 18: Suppl. 33, 318s Year: 2001
Chemotherapy for small cell lung cancer Source: Annual Congress 2006 - PG12 - Small cell lung cancer management Year: 2006
Large cell neuroendocrine carcinoma of the lung: Experience with 20 resected cases Source: Eur Respir J 2003; 22: Suppl. 45, 250s Year: 2003
Chemotherapy in advanced non small cell lung cancer Source: Eur Respir J 2005; 26: Suppl. 49, 77s Year: 2005